EIF4E and astrocytoma (excluding glioblastoma): Increased phospho-eIF4E levels is an independent prognostic factor in astrocytomas [55], NSCLC [56], and nasopharyngeal carcinoma [57], while also being associated with disease progression in melanoma [58] and prostate cancer [59].